Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Martin

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuroendocrinology|February 23, 2024
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumoursDominique S V M Clement, Monique E van Leerdam, Margot E T Tesselaar, et al.
Journal of Neuroendocrinology|March 19, 2026
Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumoursStefano Partelli, Detlef K Bartsch, Massimo Falconi, et al.
Life Sciences|November 26, 2025
Lactococcus lactis expressing IL-6 supplementation promotes the Tr17 regulatory cell differentiation in the gut and alleviates the metabolic and inflammatory dysfunction in an experimental model of diet-induced type 2 diabetesThaílla Cristina Faria Pacheco, Sara Cândida Barbosa, Jefferson Elias-Oliveira, et al.
Cellular and Molecular Life Sciences : CMLS|December 2, 2025
Lactococcus lactis-HSP65 requires TLR2 to induce tolerogenic dendritic cells and confer protection against type 1 diabetes in a murine modelJefferson Elias-Oliveira, Vanessa Fernandes Rodrigues, Ítalo Sousa Pereira, et al.
Journal of Substance Abuse Treatment|April 18, 2021
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)Elizabeth Needham Waddell, Sandra A Springer, Lisa A Marsch, et al.
Molecular Therapy. Methods & Clinical Development|July 23, 2015
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout miceVivian W Choi, Chad E Bigelow, Terri L McGee, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuroendocrinology|February 23, 2024
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumoursDominique S V M Clement, Monique E van Leerdam, Margot E T Tesselaar, et al.
Journal of Neuroendocrinology|March 19, 2026
Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumoursStefano Partelli, Detlef K Bartsch, Massimo Falconi, et al.
Life Sciences|November 26, 2025
Lactococcus lactis expressing IL-6 supplementation promotes the Tr17 regulatory cell differentiation in the gut and alleviates the metabolic and inflammatory dysfunction in an experimental model of diet-induced type 2 diabetesThaílla Cristina Faria Pacheco, Sara Cândida Barbosa, Jefferson Elias-Oliveira, et al.
Cellular and Molecular Life Sciences : CMLS|December 2, 2025
Lactococcus lactis-HSP65 requires TLR2 to induce tolerogenic dendritic cells and confer protection against type 1 diabetes in a murine modelJefferson Elias-Oliveira, Vanessa Fernandes Rodrigues, Ítalo Sousa Pereira, et al.
Journal of Substance Abuse Treatment|April 18, 2021
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)Elizabeth Needham Waddell, Sandra A Springer, Lisa A Marsch, et al.
Molecular Therapy. Methods & Clinical Development|July 23, 2015
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout miceVivian W Choi, Chad E Bigelow, Terri L McGee, et al.
Pageof 4